SCHEMBL23039573

SCHEMBL23039573

c1ccc(-n2c3ccccc3c3cc(-c4nc(-c5ccc(-n6c7ccccc7c7cc8c(cc76)sc6ccccc68)cc5)nc(-c5ccc6c(c5)c5ccccc5n6-c5ccccc5)n4)ccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.41
KDM4E B2RXH2 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PTGER4 P35408 2/20 0.37
HSD17B10 Q99714 1/20 0.33
PDE1B Q01064 1/20 0.32
PDE3A Q14432 1/20 0.32
PDE11A Q9HCR9 1/20 0.32
GPR3 P46089 1/20 0.32
HDAC4 P56524 1/20 0.32
ALDH1A1 P00352 2/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
RAC2 P15153 1/20 0.31
RAC3 P60763 1/20 0.31
CDC42 P60953 1/20 0.31
RAC1 P63000 1/20 0.31
CYP1A2 P05177 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18619169 0.94 ATM (0.42) ATMKDM4EL3MBTL1PTGER4HSD17B10
SCHEMBL23039520 0.94 ATM (0.42) ATMKDM4EL3MBTL1PTGER4HSD17B10
SCHEMBL10014532 0.94 ATM (0.41) ATMKDM4EL3MBTL1PTGER4HSD17B10
SCHEMBL18564400 0.94 L3MBTL1 (0.39) ATMKDM4EL3MBTL1PTGER4HSD17B10
SCHEMBL18505399 0.93 ATM (0.40) ATMKDM4EL3MBTL1PTGER4HSD17B10
SCHEMBL25133076 0.93 ATM (0.40) ATMKDM4EL3MBTL1PTGER4HSD17B10
SCHEMBL25662502 0.93 KDM4E (0.35) ATMKDM4EL3MBTL1PTGER4HDAC4
SCHEMBL18564415 0.92 KDM4E (0.37) ATMKDM4EL3MBTL1PTGER4GPR3
SCHEMBL18564395 0.92 KDM4E (0.37) ATMKDM4EL3MBTL1PTGER4GPR3
SCHEMBL22257660 0.92 KDM4E (0.34) ATMKDM4EL3MBTL1PTGER4GPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210066613-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2021-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210066613-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, CYBA, NDUFV3 ATM 2079/4885KDM4E 4617/4885L3MBTL1 1409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.